FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Neut Sodium Bicarbonate Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
None known.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Neut (4% sodium bicarbonate additive solution) is indicated for use as an additive to raise the pH of acid solutions administered intravenously to reduce the incidence of chemical phlebitis and patient discomfort due to vein irritation at or near the site of infusion.
History
There is currently no drug history available for this drug.
Other Information
Neut (4% sodium bicarbonate additive solution) is a sterile, nonpyrogenic solution of sodium bicarbonate in water for injection. It is administered by the intravenous route only after addition as a neutralizing agent to an acidic large volume parenteral solution. Each 5 mL contains sodium bicarbonate 0.2 g (2.4 mEq each of Na+ and HCO3‾ ); edetate disodium, anhydrous 10 mg added as a stabilizer. Total sodium (Na+) content of each 5 mL is 56.1 mg (11.2 mg/mL).
The solutions contain no bacteriostat, antimicrobial agent or added buffer; pH 8.0 (7.0 to 8.5).
Sodium Bicarbonate, USP is chemically designated as NaHCO3, a white crystalline powder soluble in water.
Sources
Neut Sodium Bicarbonate Manufacturers
-
Hospira, Inc.
Neut Sodium Bicarbonate | Hospira, Inc.
One vial (5 mL) of Neut added to a liter (1000 mL) of any of the following Hospira parenteral solutions will increase the pH to a more physiologic range. Specific pH may vary slightly from lot to lot.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.
Product
List
5% Alcohol in 5% Dextrose Injection, USP
1500
2.5% Dextrose Inj., USP
1508
5% Dextrose Inj., USP
1522
10% Dextrose Inj., USP
1530
20% Dextrose Inj., USP
1535
Ringer’s Injection, USP
1582
0.9% Sodium Chloride Inj., USP
1583
Sodium Lactate Inj., USP (1/6 Molar)
1587
Addition of one vial of Neut to one-half liter (500 mL) is recommended to achieve a more physiologic pH of the following Hospira parenteral solutions:
Product
List
6% Dextran 70 and 0.9% Sodium Chloride Injection
1505
6% Dextran 70 and 5% Dextrose Injection
1507
Note: Some products, e.g., Aminosyn® solutions and those Ionosol® and Normosol® formulas containing dextrose will NOT be brought to near physiologic pH by the addition of Neut. This is due to the relatively high buffer capacity of these fluids.
-
Hospira, Inc.
Neut Sodium Bicarbonate | Hospira, Inc.
One vial (5 mL) of Neut added to a liter (1000 mL) of any of the following Hospira parenteral solutions will increase the pH to a more physiologic range. Specific pH may vary slightly from lot to lot.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.
Product
List
5% Alcohol in 5% Dextrose Injection, USP
1500
2.5% Dextrose Inj., USP
1508
5% Dextrose Inj., USP
1522
10% Dextrose Inj., USP
1530
20% Dextrose Inj., USP
1535
Ringer’s Injection, USP
1582
0.9% Sodium Chloride Inj., USP
1583
Sodium Lactate Inj., USP (1/6 Molar)
1587
Addition of one vial of Neut to one-half liter (500 mL) is recommended to achieve a more physiologic pH of the following Hospira parenteral solutions:
Product
List
6% Dextran 70 and 0.9% Sodium Chloride Injection
1505
6% Dextran 70 and 5% Dextrose Injection
1507
Note: Some products, e.g., AminosynTM solutions and those IonosolTM and NormosolTM formulas containing dextrose will NOT be brought to near physiologic pH by the addition of Neut. This is due to the relatively high buffer capacity of these fluids.
COMPATIBILITY & EFFECTIVENESS OF NEUT WITH ADDITIVES TO 5% DEXTROSE INJECTION (D5-W)
When medications are added to intravenous solutions, the resultant admixtures may or may not be compatible in solutions containing Neut (4% sodium bicarbonate additive solution).Following is a list of medications each added to one liter of 5% Dextrose Injection, USP (D5‑W) classified according to their effect with Neut (4% sodium bicarbonate additive solution).
1. Neut Compatible with Admixtures for 24 Hours
Conc./liter
ACTHAR® (ACTH)
40 units
Aqua-Mephyton® (Vitamin K1)
10 mg
Aramine® (metaraminol) Bitartrate
100 mg†
Atropine Sulfate
0.4 mg
Calcium Chloride
1 g
Calcium Gluceptate
1.1 g
Compazine® (prochlorperazine) Edisylate
10 mg
Crystodigin® (digitoxin)
0.2 mg
Demerol® (meperidine) HCl
100 mg
Ergonovine Maleate
0.2 mg
Erythrocin® (erythromycin) Lactobionate
1 g
Fungizone® (amphotericin B)
50 mg
Ilotycin® (erythromycin) Gluceptate
1 g
Innovar® (droperidol and fentanyl)
1.0 mL
Keflin® (cephalothin) Sodium
4 g
Lidocaine HCl
1 g
M.V.I.TM (multivitamin infusion)
10 mL†
Neosynephrine® (phenylephrine) HCl
10 mg
Panheparin® (heparin sodium)
20,000 units
Penicillin G Potassium
100,000,000 units
Pitocin® (oxytocin)
5 units
Potassium Chloride
120 mEq
Sodium Iodide
1 g
(promazine) HCl
100 mg
Vancocin® (vancomycin) HCl
500 mg
Wydase® (hyaluronidase)
150 units
†Requires 2 vials of Neut to bring admixture to approximate neutrality.
2. Neut Incompatible –Additive Inactivated at Neutral pH
Conc./liter
Epinephrine
4 mg
IsuprelTM (isoproterenol) HCl
1 mg
LevophedTM (levarterenol) Bitartrate
8 mg
QuelicinTM (succinylcholine chloride)
1 g
3. Neut Ineffective -Additive High in Titratable Acidity
Conc./liter
Achromycin® (tetracycline) HCl
500 mg
Aureomycin® (chlortetracycline) HCl
500 mg
Bejectal w/C (B complex and C)
10 mL
Kantrex® (kanamycin) Sulfate
1 g
4. Neut Not Indicated –Admixture Already At or Near Neutrality
Conc./liter
Gantrisin® (sulfisoxazole) Diethanolamine
4 g
Hydrocortone® (hydrocortisone) Phosphate
100 mg
Prostaphlin® (oxacillin) Sodium
500 mg
Sodium Bicarbonate
3.75 g
Solu-Cortef ® (hydrocortisone sodium succinate)
250 mg
It should be noted that the admixtures were evaluated for physical compatibility, not for pharmacological compatibility. It, therefore, would be erroneous to circumvent medical judgment which must be involved in administering any solution that appears to be compatible on the basis of having no visible haze or precipitate. The inclusion of drugs in this study of their compatibility in solution does not imply their therapeutic usefulness or safety. This matter remains the judgment of the prescribing physician.
NOTE: The compatibility information contained herein is based on the studies involving Hospira dextrose only. Variations in compatibility could occur due to lot-to-lot variations or formula changes in the additives or dextrose solutions of other manufacturers.
Login To Your Free Account